Centogene Other Operating Expenses vs Total Revenue Analysis
CNTG Stock | USD 0.10 0.02 12.92% |
Centogene financial indicator trend analysis is way more than just evaluating Centogene B V prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Centogene B V is a good investment. Please check the relationship between Centogene Other Operating Expenses and its Total Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centogene B V. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Other Operating Expenses vs Total Revenue
Other Operating Expenses vs Total Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Centogene B V Other Operating Expenses account and Total Revenue. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Centogene's Other Operating Expenses and Total Revenue is 0.98. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Centogene B V, assuming nothing else is changed. The correlation between historical values of Centogene's Other Operating Expenses and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of Centogene B V are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Other Operating Expenses i.e., Centogene's Other Operating Expenses and Total Revenue go up and down completely randomly.
Correlation Coefficient | 0.98 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Centogene B V. It is also known as Centogene overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Revenue
Total revenue comprises all receipts Centogene B V generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Most indicators from Centogene's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Centogene B V current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centogene B V. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. At this time, Centogene's Tax Provision is most likely to increase significantly in the upcoming years. The Centogene's current Enterprise Value is estimated to increase to about 173.6 M, while Discontinued Operations is projected to decrease to roughly 4.3 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 851K | 3.6M | 8.2M | 8.6M | Depreciation And Amortization | 20.8M | 10.2M | 7.5M | 9.6M |
Centogene fundamental ratios Correlations
Click cells to compare fundamentals
Centogene Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Centogene fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 117.5M | 150.1M | 90.7M | 92.8M | 77.2M | 95.8M | |
Short Long Term Debt Total | 27.0M | 24.1M | 22.8M | 60.1M | 80.4M | 84.4M | |
Other Current Liab | 13.1M | 20.5M | 19.6M | 10.1M | 8.6M | 10.6M | |
Total Current Liabilities | 29M | 57.1M | 39.5M | 24.7M | 43.4M | 36.5M | |
Total Stockholder Equity | 59.9M | 65.7M | 27.3M | 7.4M | (25.3M) | (24.0M) | |
Other Liab | 11.2M | 9.9M | 9.2M | 8.1M | 9.3M | 9.9M | |
Net Tangible Assets | 45.7M | 53.3M | 18.1M | 11K | 12.7K | 12.0K | |
Property Plant And Equipment Net | 33.3M | 38.7M | 27.1M | 22.2M | 19.3M | 23.4M | |
Net Debt | (9.6M) | (19.1M) | 9.4M | 28.1M | 61.3M | 64.4M | |
Retained Earnings | (40.6M) | (62.9M) | (109.3M) | (141.3M) | (177.4M) | (168.5M) | |
Accounts Payable | 8.6M | 31.7M | 11.3M | 6.3M | 5.6M | 11.0M | |
Cash | 36.6M | 43.2M | 13.4M | 32.0M | 19.1M | 21.7M | |
Non Current Assets Total | 49.4M | 53.1M | 39.2M | 33.0M | 33.2M | 32.4M | |
Non Currrent Assets Other | 1.9M | 2.0M | 3.0M | 3.4M | 3.4M | 4.9M | |
Other Assets | 0.0 | 1.9M | 2.0M | 3.0M | 3.4M | 3.6M | |
Long Term Debt | 12.9M | 1.6M | 401K | 40.1M | 39.9M | 41.9M | |
Cash And Short Term Investments | 36.6M | 43.2M | 13.4M | 32.0M | 19.1M | 21.7M | |
Net Receivables | 19.4M | 29.2M | 24.3M | 16.5M | 19.4M | 18.4M | |
Common Stock Total Equity | 262K | 322K | 2.4M | 2.7M | 3.1M | 3.2M | |
Common Stock Shares Outstanding | 16.4M | 20.9M | 22.4M | 26.8M | 28.2M | 24.0M | |
Liabilities And Stockholders Equity | 117.5M | 150.1M | 90.7M | 92.8M | 77.2M | 90.8M | |
Non Current Liabilities Total | 29.6M | 27.2M | 23.7M | 60.7M | 53.4M | 32.7M | |
Capital Lease Obligations | 21.7M | 21.2M | 19.0M | 15.4M | 14.6M | 13.5M | |
Inventory | 1.8M | 11.4M | 3.9M | 1.8M | 2.5M | 3.3M | |
Other Current Assets | 5.8M | 8.3M | 5.5M | 5.5M | 3.1M | 5.3M | |
Other Stockholder Equity | 106.5M | (851K) | 27.5M | 121.1M | 139.3M | 146.2M | |
Total Liab | 58.6M | 84.4M | 63.2M | 85.4M | 96.8M | 70.3M | |
Property Plant And Equipment Gross | 33.3M | 38.7M | 52.0M | 48.5M | 50.1M | 40.6M | |
Short Long Term Debt | 3.7M | 2.5M | 3.8M | 4.6M | 25.9M | 27.2M | |
Total Current Assets | 68.1M | 97.0M | 51.5M | 59.8M | 44.1M | 51.1M | |
Accumulated Other Comprehensive Income | 98.1M | 125.9M | 133.9M | 145.4M | 148.1K | 140.7K | |
Non Current Liabilities Other | 9.9M | 640K | 960K | 202K | 48K | 45.6K | |
Short Term Debt | 7.3M | 3.5M | 7.1M | 6.9M | 28.1M | 29.5M | |
Intangible Assets | 14.1M | 12.4M | 9.2M | 7.4M | 6.9M | 10.0M | |
Common Stock | 2.4M | 2.7M | 2.7M | 3.3M | 3.5M | 2.1M | |
Property Plant Equipment | 39.1M | 33.3M | 38.7M | 27.1M | 31.1M | 35.3M | |
Net Invested Capital | 65.1M | 68.6M | 31.1M | 52.1M | 40.5M | 52.5M | |
Net Working Capital | 39.1M | 39.9M | 12.0M | 35.2M | 653K | 620.4K |
Currently Active Assets on Macroaxis
When determining whether Centogene B V is a strong investment it is important to analyze Centogene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Centogene's future performance. For an informed investment choice regarding Centogene Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centogene B V. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Centogene. If investors know Centogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Centogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.39) | Revenue Per Share 1.723 | Quarterly Revenue Growth (0.08) | Return On Assets (0.27) | Return On Equity (13.75) |
The market value of Centogene B V is measured differently than its book value, which is the value of Centogene that is recorded on the company's balance sheet. Investors also form their own opinion of Centogene's value that differs from its market value or its book value, called intrinsic value, which is Centogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Centogene's market value can be influenced by many factors that don't directly affect Centogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Centogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Centogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Centogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.